Korean J Hematol 2012; 47(2):
Published online June 26, 2012
https://doi.org/10.5045/kjh.2012.47.2.150
© The Korean Society of Hematology
1Department of Hemato-oncology, Korea University Medical Center, Anam Hospital, Seoul, Korea.
2Department of Pathology, Korea University Medical Center, Anam Hospital, Seoul, Korea.
Correspondence to : Correspondence to In Sun Kim, M.D., Ph.D. Department of Pathology, Korea University Medical Center, Anam Hospital, Anam-dong 5 ga, Sungbuk-gu, Seoul 152-703, Korea. Tel: +82-2-920-5594, Fax: +82-2-953-3130, iskim@korea.ac.kr
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Interdigitating dendritic cell sarcoma (IDCS) is a very rare and aggressive neoplasm that arises from antigen presenting cells. IDCS usually involves lymph nodes; however, extra-nodal involvement has also been reported. Because a consistent standard therapy for IDCS has not been established to date, we report a case of the successful treatment of disseminated IDCS using ABVD chemotherapy (doxorubicin, bleomycin, vinblastine, and dacarbazine). A 64-year-old man was diagnosed with IDCS on the basis of immunohistochemical findings of a biopsy specimen of the inferior nasal concha. Immunohistochemical staining showed a positive reaction for CD68, leukocyte common antigen, and S-100 protein, but a negative reaction for CD34, CD1a, and CD21. Imaging studies showed cervical and axillary lymphadenopathies, subcutaneous nodules, and a soft tissue lesion in the nasal cavity. Treatment with the ABVD regimen resulted in complete remission after 8 cycles of chemotherapy.
Keywords IDCS, ABVD chemotherapy, Complete remission
Korean J Hematol 2012; 47(2): 150-153
Published online June 26, 2012 https://doi.org/10.5045/kjh.2012.47.2.150
Copyright © The Korean Society of Hematology.
Suk-young Lee1, Se Ryeon Lee1, Won Jin Chang1, Hye Sook Kim1, Byung Soo Kim1, and In Sun Kim2*
1Department of Hemato-oncology, Korea University Medical Center, Anam Hospital, Seoul, Korea.
2Department of Pathology, Korea University Medical Center, Anam Hospital, Seoul, Korea.
Correspondence to: Correspondence to In Sun Kim, M.D., Ph.D. Department of Pathology, Korea University Medical Center, Anam Hospital, Anam-dong 5 ga, Sungbuk-gu, Seoul 152-703, Korea. Tel: +82-2-920-5594, Fax: +82-2-953-3130, iskim@korea.ac.kr
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Interdigitating dendritic cell sarcoma (IDCS) is a very rare and aggressive neoplasm that arises from antigen presenting cells. IDCS usually involves lymph nodes; however, extra-nodal involvement has also been reported. Because a consistent standard therapy for IDCS has not been established to date, we report a case of the successful treatment of disseminated IDCS using ABVD chemotherapy (doxorubicin, bleomycin, vinblastine, and dacarbazine). A 64-year-old man was diagnosed with IDCS on the basis of immunohistochemical findings of a biopsy specimen of the inferior nasal concha. Immunohistochemical staining showed a positive reaction for CD68, leukocyte common antigen, and S-100 protein, but a negative reaction for CD34, CD1a, and CD21. Imaging studies showed cervical and axillary lymphadenopathies, subcutaneous nodules, and a soft tissue lesion in the nasal cavity. Treatment with the ABVD regimen resulted in complete remission after 8 cycles of chemotherapy.
Keywords: IDCS, ABVD chemotherapy, Complete remission
Histological features of the nasal cavity include diffuse infiltration of spindle cells, large pleomorphic cells, foamy histiocytes, and various inflammatory cells
Computed tomography (CT) scans show multiple lymphadenopathies in both axillae
CT scans after 8 cycles of ABVD (adriamycin, bleomycin, vinblastine, and dacarbazine) shows complete resolution of axillary lymphadenopathies
Hee Je Kim, Woo Sung Min, Yoon Hee Park, Soo Jeong Park, Jong Wook Lee, jong Youl Jin, Chi Hwa Han, Chong Won Park, Chun Choo Kim
Korean J Hematol 2003; 38(4): 228-233Woo Chang Lee, Chan Jeoung Park, Eul Joo Seo, Hyun Sook Chi, Jong Jin Seo, Tadh.T.Ghim, Hyung Nam Moon
Korean J Hematol 2000; 35(1): 34-39Myoung Joon Song, Dong, Gun Lee, Suk Min Seo, Won Chul Kim, Hong Gern Bin, Hyun Young Woo, Yeon Joo Jun, Seok Goo Cho, Byung Cheol Son, Hae Kyung Lee
Korean J Hematol 2005; 40(3): 167-171
Histological features of the nasal cavity include diffuse infiltration of spindle cells, large pleomorphic cells, foamy histiocytes, and various inflammatory cells
Computed tomography (CT) scans show multiple lymphadenopathies in both axillae
CT scans after 8 cycles of ABVD (adriamycin, bleomycin, vinblastine, and dacarbazine) shows complete resolution of axillary lymphadenopathies